Literature DB >> 19236787

[Wnt/beta-catenin signal pathway and malignant hematological disease -- review].

Yun-Xiu Wang1, Ji-Hong Zhang, Zhao-Wei Gu.   

Abstract

Wnt/beta-catenin is the most important and more understanding pathway in Wnt pathways, which is closely related to pathogenesis and development of many solid tumors. Recently, researches discovered that Wnt/beta-catenin signal pathway may be involved in malignant hematopoiesis, and abnormally activated in many hematological-malignancies. This article reviews the newest studies on relationship between Wnt/beta-catenin signal pathway and hematological malignancies (multiple myeloma, chronic myeloid leukemia, chronic lymphocytic leukemia, acute leukemia and so on) in order to reveal the related pathogenesis of hematological malignancies and provide new opinions for target therapy of these diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19236787

Source DB:  PubMed          Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi        ISSN: 1009-2137


  3 in total

1.  CKD-581 Downregulates Wnt/β-Catenin Pathway by DACT3 Induction in Hematologic Malignancy.

Authors:  Soo Jin Kim; Suntae Kim; Yong June Choi; U Ji Kim; Keon Wook Kang
Journal:  Biomol Ther (Seoul)       Date:  2022-07-04       Impact factor: 4.231

2.  Understanding and Targeting the Wnt/β-Catenin Signaling Pathway in Chronic Leukemia.

Authors:  S Thanendrarajan; Y Kim; I G H Schmidt-Wolf
Journal:  Leuk Res Treatment       Date:  2011-12-04

3.  Kinesin Family Member 11 Enhances the Self-Renewal Ability of Breast Cancer Cells by Participating in the Wnt/β-Catenin Pathway.

Authors:  Yuan-Yuan Pei; Gao-Chi Li; Jian Ran; Xin-Hong Wan; Feng-Xiang Wei; Lan Wang
Journal:  J Breast Cancer       Date:  2019-11-07       Impact factor: 3.588

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.